SCHEMBL7903133

SCHEMBL7903133

N#CC(CC(=O)O)(C(=O)O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.48
HIF1A Q16665 1/20 0.48
ALDH1A1 P00352 3/20 0.41
TSHR P16473 1/20 0.41
CYP1A2 P05177 2/20 0.39
ATM Q13315 1/20 0.36
MAPT P10636 3/20 0.35
MIF P14174 1/20 0.35
CYP2D6 P10635 3/20 0.35
CCR1 P32246 2/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
HTT P42858 1/20 0.35
SLC13A5 Q86YT5 2/20 0.35
S1PR4 O95977 1/20 0.33
LMNA P02545 1/20 0.33
S1PR1 P21453 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701485 0.81 ALDH1A1 (0.41) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL11823794 0.80 ALDH1A1 (0.40) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL11020942 0.80 SMN1; SMN2 (0.47) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL5499470 0.77 CYP2C19 (0.52) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL8018070 0.74 CYP2C19 (0.57) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL27560876 0.73 MAPT (0.40) CYP2C19HIF1AALDH1A1TSHRCYP1A2
SCHEMBL7900944 0.73 CYP2C9 (0.47) ALDH1A1MAPTSMN1; SMN2
SCHEMBL119698 0.71 MAPT (0.47) CYP2C19HIF1AALDH1A1CYP1A2MAPT
SCHEMBL10988395 0.71 MAPT (0.40) CYP2C19HIF1AALDH1A1TSHRATM
SCHEMBL10635869 0.71 MAPT (0.40) CYP2C19HIF1AALDH1A1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337682-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS Carmot Therapeutics Inc. (US) 2024-03-20 EP disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
US-6190841-B1 ACID GENERATOR WHICH GENERATES AN ACID WHEN IRRADIATED WITH ACTINIC RADIATION, AND COMPOUND CONTAINING CARBOXYL GROUPS, WHICH CAN DECOMPOSE UPON DECARBOXYLATION KABUSHIKI KAISHA TOSHIBA (JP) 2001-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR CYP2C19 4624/4885HIF1A 2144/4885ALDH1A1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.